88 related articles for article (PubMed ID: 7638732)
1. In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta.
Peplinski GR; Tsung K; Meko JB; Norton JA
Surgery; 1995 Aug; 118(2):185-90; discussion 190-1. PubMed ID: 7638732
[TBL] [Abstract][Full Text] [Related]
2. In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta.
Peplinski GR; Tsung AK; Casey MJ; Meko JB; Fredrickson TN; Buller RM; Norton JA
Cancer J Sci Am; 1996; 2(1):21-7. PubMed ID: 9166494
[TBL] [Abstract][Full Text] [Related]
3. Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta.
Peplinski GR; Tsung K; Whitman ED; Meko JB; Norton JA
Ann Surg Oncol; 1995 Mar; 2(2):151-9. PubMed ID: 7728569
[TBL] [Abstract][Full Text] [Related]
4. Prevention of murine breast cancer by vaccination with tumor cells modified by cytokine-producing recombinant vaccinia viruses.
Peplinski GR; Tsung K; Meko JB; Norton JA
Ann Surg Oncol; 1996 Jan; 3(1):15-23. PubMed ID: 8770297
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12.
Meko JB; Tsung K; Norton JA
Surgery; 1996 Aug; 120(2):274-82; discussion 282-3. PubMed ID: 8751593
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
[TBL] [Abstract][Full Text] [Related]
7. Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases.
Gnant MF; Puhlmann M; Bartlett DL; Alexander HR
Ann Surg; 1999 Sep; 230(3):352-60; discussion 360-1. PubMed ID: 10493482
[TBL] [Abstract][Full Text] [Related]
8. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
9. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors.
Ding I; Huang K; Snyder ML; Cook J; Zhang L; Wersto N; Okunieff P
J Natl Cancer Inst; 1996 Oct; 88(19):1399-404. PubMed ID: 8827018
[TBL] [Abstract][Full Text] [Related]
10. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
Chen B; Timiryasova TM; Andres ML; Kajioka EH; Dutta-Roy R; Gridley DS; Fodor I
Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286
[TBL] [Abstract][Full Text] [Related]
12. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy.
Whitman ED; Tsung K; Paxson J; Norton JA
Surgery; 1994 Aug; 116(2):183-8. PubMed ID: 8047984
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution.
Jackaman C; Nelson DJ
Cancer Gene Ther; 2010 Jun; 17(6):429-40. PubMed ID: 20150930
[TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: induction and potentiation of antitumor responses.
Uzendoski K; Kantor JA; Abrams SI; Schlom J; Hodge JW
Hum Gene Ther; 1997 May; 8(7):851-60. PubMed ID: 9143911
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
[TBL] [Abstract][Full Text] [Related]
17. Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.
Kaufman HL; Flanagan K; Lee CS; Perretta DJ; Horig H
Vaccine; 2002 Mar; 20(13-14):1862-9. PubMed ID: 11906776
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
[TBL] [Abstract][Full Text] [Related]
19. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
20. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.
Meko JB; Yim JH; Tsung K; Norton JA
Cancer Res; 1995 Nov; 55(21):4765-70. PubMed ID: 7585501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
